Welcome to our dedicated page for Marsh & Mclennan SEC filings (Ticker: MRSH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Marsh (NYSE: MRSH) SEC filings page on Stock Titan is designed to help investors and analysts review the company’s regulatory disclosures in a structured way. While recent SEC filings are not listed in the available data, this page is where users can access Marsh’s future submissions to the US Securities and Exchange Commission once they are posted to EDGAR.
For a company that describes itself as a global leader in risk, reinsurance and capital, people and investments, and management consulting, key filings such as annual reports on Form 10-K and quarterly reports on Form 10-Q can provide important detail on business segments, risk factors, and financial performance. Current reports on Form 8-K may highlight material events, including dividend declarations or other board decisions affecting Marsh’s common stock.
When available, proxy statements and related filings can offer additional information on governance and executive matters, while Form 4 filings can be used to track transactions by directors and certain officers in Marsh’s equity.
Stock Titan enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. Users can quickly see what has changed from one period to the next, identify notable disclosures, and then drill into the full text for deeper analysis. Real-time updates from EDGAR ensure that new Marsh filings appear promptly, while AI-generated insights help reduce the time required to interpret complex regulatory documents.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported new equity awards. He received 28,586 stock options that were granted on February 24, 2026 and will vest in four equal annual installments on February 24 of 2027, 2028, 2029 and 2030.
Tomlinson was also granted 1,609 restricted stock units tied to performance stock units originally awarded on February 23, 2023 for the 2023–2025 performance period, with the performance factor determined on February 24, 2026. Both instruments convert into Marsh & McLennan common stock on a 1-for-1 basis.
Marsh & McLennan Companies, Inc. has appointed Peter Harrison, age 59, as an independent member of its board of directors, effective February 25, 2026. With his addition, the Board now consists of 13 directors.
Harrison brings more than three decades of investment management and executive leadership experience, including serving as CEO of Schroders plc and senior roles at RWC Partners and Deutsche Bank’s asset management businesses. He currently chairs Morgan Sindall plc’s board and serves on Lazard, Inc.’s board, alongside multiple industry and community leadership roles.
Marsh & McLennan Companies, Inc. issued $600 million aggregate principal amount of 4.950% Senior Notes due 2036. The notes were purchased by an underwriting group led by Citigroup Global Markets, J.P. Morgan Securities and Wells Fargo Securities under an underwriting agreement dated February 11, 2026.
The notes were issued under Marsh & McLennan’s existing base indenture dated July 15, 2011, as supplemented by a Twenty-First Supplemental Indenture dated February 19, 2026. They were registered on the company’s effective Form S-3 shelf registration statement and offered using a base prospectus and a dated prospectus supplement.
Marsh & McLennan Companies director Morton O. Schapiro reported compensation-related equity activity in company stock units. He acquired 237.74 restricted stock units on February 15, 2026 as a grant, and 456.03 units on February 13, 2026 through dividend equivalents and director fees under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
Marsh & McLennan Companies director Anthony Anderson reported administrative updates to his equity holdings. On February 13, 2026, an entry labeled as an “other” transaction involved 80.98 restricted stock units under the Directors Stock Plan, tied to a reference price of $172.98 per unit.
Footnotes explain these restricted stock units accrue from dividend equivalents and convert into common stock on a 1-for-1 basis. Following these updates, Anderson reported 15,644.66 restricted stock units and 2,014.102 common shares held directly. The activity reflects plan-related credits rather than open-market buying or selling.
MARSH & MCLENNAN COMPANIES director Deborah C. Hopkins reported an administrative equity adjustment. On February 13, 2026, she had 103.28 restricted stock units credited to her account as dividend equivalents under the Directors Stock Compensation Plan. These restricted stock units convert into common stock on a 1-for-1 basis, bringing her directly held restricted stock unit balance to 19,952.92 units following the transaction.
Marsh & McLennan Companies director Tamara Ingram reported an automatic increase in equity-based compensation. She received 39.82 restricted stock units as dividend equivalents under the company’s Directors Stock Compensation Plan, each convertible into one share of common stock, bringing her directly held restricted stock units to 7,693.42.
MARSH & MCLENNAN COMPANIES director Lloyd M. Yates reported stock-based compensation activity involving restricted stock units that convert into common shares on a 1-for-1 basis. On February 15, he received 208.92 restricted stock units at a reference price of $173.51 per unit as a grant under the Directors Stock Compensation Plan. On February 13, an additional 54.59 restricted stock units at $172.98 per unit were credited as dividend equivalents and director fee-related awards. Following these transactions, his directly held restricted stock units totaled 10,755.18.
Marsh & McLennan Companies director Jane H. Lute reported new equity-based compensation in the form of restricted stock units. On February 15, 2026, she acquired 156.69 restricted stock units at $173.51 per unit as a grant or award, bringing her direct holdings to 7,351.38 units.
On February 13, 2026, an additional 37.24 units at $172.98 were credited as an "other" transaction, tied to dividend equivalents and director fees under the company’s Directors Stock Compensation Plan. Each restricted stock unit converts into one share of Marsh & McLennan Companies common stock.
Marsh & McLennan Companies director Jan Siegmund reported a small change in his equity holdings. On February 13, 2026, he received 4.88 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan as dividend equivalents credited to his account.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Siegmund directly holds a total of 943.13 restricted stock units under this plan.